Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
08:38
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

WFH 2014 World Congress

 

11-15 May 2014 Melbourne
FAQs
   
Discussion forum - WFH 2014 World Congress
    Topic - Inhibitors, Pathogenesis, Prevention and Treatment

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 40
Visits: 73
Title: F8 genotype specific inhibitor risks in Argentine patients with severe HA and particular risk estimation of different mutation types.
Authors: Carlos De Brasi , Liliana Rossetti, Claudia Radic, Martín Abelleyro, Vanina Marchione, Irupé Szurkalo, Laura Primiani, Daniela Neme, Miguel Candela, Miguel de Tezanos Pinto, Carlos De Brasi.
Centre: IMEX, CONICET-Academia Nacional de Medicina (ANM); Fundación de la Hemofilia Alfredo Pavlovsky; IIHEMA, ANM.

You must be registered to reply or comment.

F8 GENOTYPE SPECIFIC INHIBITOR RISKS IN ARGENTINE PATIENTS WITH SEVERE HA AND PARTICULAR RISK ESTIMATION OF DIFFERENT MUTATION TYPES.

Carlos De Brasi
Thread initiator
Subspeciality
Reg: 4/23/2014 8:37:00 PM

Comment# 1

We present mutation specific inhibitor risks in our series of patients with severe HA, which can be obtained in approximately 15-20 days, as a valuable data for designing fitted therapies and follow-up protocols.

Comment added on 4/23/2014 8:37:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 2526
Title: A WEB SITE TO IMPROVE MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT: RESULTS AT 2 YEARS
Authors: Annarita Tagliaferri ,
Centre: Centro di Riferimento Regionale per la cura dellEmofilia

Poster most viewed in this topic
Poster: 63
Visits: 314
Title: A Phase III clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in hemophilia patients with inhibitors: hemostatic efficacy and safety
Authors: YUICHI SHINKODA ,
Centre: Kagoshima City Hospital


 








PosterSessionOnline
Logo Draft
 
Logo Cert